Skip to content
Clinical Trials – home

Azienda Socio Sanitaria Territoriale Della Valle Olona

Verified siteinfo

Italy Piazza Don Giuseppe Borella 1, 21047 Saronno, Italy

  • 5 trials recruiting
  • Atrial fibrillation · Non-small cell lung cancer · Craniocerebral injury
  • Adult patients

About Specializations

Azienda Socio Sanitaria Territoriale Della Valle Olona in Saronno, Italy specialises in clinical trials of conditions such as Atrial fibrillation, Non-small cell lung cancer, Craniocerebral injury, Dialysis, and other specialisations. This site conducts important research.

Main research areas of the site

Nervous System Diseases and Traumatic Brain Injury Research

At Azienda Socio Sanitaria Territoriale Della Valle Olona in Saronno, the Neuroscience department is involved in clinical research focused on nervous system diseases, with a strong emphasis on subacute moderate to severe traumatic brain injury. These studies are designed to assess the safety and tolerability of a new treatment approach and to explore its potential to support recovery in adults with brain injury.

  • Study of traumatic brain injury care in adults with moderate to severe injury
  • Evaluation of a new intranasal therapy for safety, tolerability, and possible clinical benefit
  • Research aimed at improving treatment options in neurorehabilitation

This work reflects a small but focused effort to advance neurologic care through early clinical testing and better understanding of treatment effects.

Nutritional and Metabolic Diseases in Chronic Dialysis Care

The site is also conducting research in nutritional and metabolic diseases, centered on end stage kidney disease in people receiving chronic dialysis therapy. The trial is examining whether a potassium-binding treatment can help patients reduce strict dietary potassium limits without increasing the risk of hyperkalemia, while also looking at quality of life and nutrition.

  • End stage kidney disease in patients on chronic dialysis
  • Assessment of a treatment intended to support safer potassium control
  • Interest in improving dietary flexibility, nutrition, and patient well-being

At this hospital/clinic, the research combines kidney care and nutrition-focused outcomes to better understand how treatment may improve everyday management for dialysis patients.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Piazza Don Giuseppe Borella 121047 SaronnoItaly
Recruiting now
5 trials
Conditions studied
9
Partner status
Verified site

More sites in SaronnoItaly

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

Phase 2a Study of Safety, Tolerability and Efficacy of Intranasal Cenegermin in Adults with Moderate to Severe Subacute Traumatic Brain Injury

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cenegermin
  • Sponsor:Dompe' Farmaceutici S.p.A.

Study on the Effectiveness of Abelacimab for High-Risk Atrial Fibrillation Patients Unsuitable for Oral Anticoagulation

Investigational
Countries:ItalyItaly
  • Participants:65+ years
  • Substances:Abelacimab
  • Sponsor:Anthos Therapeutics Inc.

Study of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Patiromer
  • Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri

Ovarian cancer

Recruiting

Study on Olaparib for Maintenance Therapy in Patients with Newly Diagnosed Advanced Ovarian, Fallopian Tube, and Peritoneal Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Olaparib
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale

Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Consorzio Oncotech

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Osimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Universita' Degli Studi Di Torino

Atrial fibrillation

Not yet recruiting

Stroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)

Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:REGN7508
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study of Cemiplimab, Platinum and Gemcitabine in Treatment‑Naïve Patients with Advanced Squamous Non‑Small Cell Lung Cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years
  • Substances:Cemiplimab
  • Sponsor:GOIRC Gruppo Oncologico Italiano Di Ricerca Clinica

Non-small cell lung cancer

Not yet recruiting

Study of Cabozantinib for Patients with Non-Small Cell Lung Cancer and MET Deregulation

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Cabozantinib
  • Sponsor:Fondazione Ricerca Traslazionale

Non-small cell lung cancer

Not yet recruiting

Study on the Best Treatment Sequence for Advanced Non-Small Cell Lung Cancer with EGFR Mutations Using Dacomitinib and Osimertinib

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dacomitinib
  • Sponsor:Fondazione Ricerca Traslazionale
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.